Philip Young
Chief Executive Officer at LOBE SCIENCES LTD.
Net worth: 7 800 $ as of 29/04/2024
Profile
Philip J.
Young is the founder of Exactus Biosolutions, Inc. He is currently the Chairman, Chief Executive Officer & Secretary at Lobe Sciences Ltd.
He previously held positions as the President, Chief Executive Officer & Director at AmpliPhi Biosciences Corp.
from 2011 to 2014, Chief Executive Officer & Director at Exactus, Inc. in 2019, President, CEO, CFO, Secretary & CAO at Osteologix Holdings Plc from 2010 to 2012, Chief Executive Officer at Gantech International, Inc. from 2000 to 2004, President & Chief Executive Officer at TrippBio, Inc., Director at Woodbrook Group Holdings, Inc., Director of Affairs & Director General at Pharmacia SAS, Chief Business Officer & Executive Vice President at Insmed, Inc. from 2004 to 2007, President & Chief Operating Officer at AGY Therapeutics, Inc. from 2000 to 2004, and Vice President & General Manager at Neurex Pharmaceuticals from 1998 to 2000.
Mr. Young obtained his undergraduate degree from James Madison University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LOBE SCIENCES LTD
0.63% | 16/04/2024 | 487,500 ( 0.63% ) | 7 800 $ | 29/04/2024 |
Philip Young active positions
| Companies | Position | Start |
|---|---|---|
| LOBE SCIENCES LTD. | Chief Executive Officer | 14/01/2021 |
Former positions of Philip Young
| Companies | Position | End |
|---|---|---|
| PANACEA LIFE SCIENCES HOLDINGS, INC. | Chief Executive Officer | 30/07/2019 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Chief Executive Officer | 30/11/2014 |
| OSTEOLOGIX HOLDINGS PLC | Director of Finance/CFO | - |
| WOODBROOK GROUP HOLDINGS INC. | Director/Board Member | 18/11/2008 |
| INSMED INCORPORATED | Corporate Officer/Principal | 06/03/2007 |
Training of Philip Young
| James Madison University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| WOODBROOK GROUP HOLDINGS INC. | Finance |
| LOBE SCIENCES LTD. | Process Industries |
| Private companies | 9 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
AGY Therapeutics, Inc.
 AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Exactus, Inc.
 Exactus, Inc. Miscellaneous Commercial ServicesCommercial Services Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The firm's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company was founded in 2008 and is headquartered in Delray Beach, FL. | Commercial Services |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
| Pharmacia SAS | |
| Gantech International, Inc. | |
| Neurex Pharmaceuticals | |
Exactus Biosolutions, Inc.
 Exactus Biosolutions, Inc. Miscellaneous Commercial ServicesCommercial Services Exactus Biosolutions, Inc. operates as a life science company that develops and commercializes point-of-care diagnostics for measuring proteolytic enzymes in the blood based on a proprietary detection platform. The company was founded by Phillip J. Young and Timothy Ryan and is headquartered in New York, NY. | Commercial Services |
TrippBio, Inc.
 TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services TrippBio, Inc. engages in biotechnology industry. The company is headquartered in Jacksonville, FL. | Commercial Services |
- Stock Market
- Insiders
- Philip Young
